Author:
Moassefi Mana,Faghani Shahriar,Conte Gian Marco,Kowalchuk Roman O.,Vahdati Sanaz,Crompton David J.,Perez-Vega Carlos,Cabreja Ricardo A. Domingo,Vora Sujay A.,Quiñones-Hinojosa Alfredo,Parney Ian F.,Trifiletti Daniel M.,Erickson Bradley J.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Reference50 articles.
1. Tamimi AF, Juweid M (2017) Epidemiology and outcome of glioblastoma. In: De Vleeschouwer S (ed) Glioblastoma. Brisbane, AU: Codon Publications
2. Tesileanu CMS, Dirven L, Wijnenga MMJ, Koekkoek JAF, Vincent AJPE, Dubbink HJ et al (2020) Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria. Neuro Oncol 22:515–523
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
4. Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE (2007) Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol 82:81–83
5. Brandes A, Tosoni A, Franceschi E, Blatt V, Ermani M (2007) Pseudoprogression after concomitant radio-chemotherapy treatment in newly diagnosed glioblastoma patients and potential correlation with MGMT methylation status. Neuro Oncol Oxford University Press (OUP) 9:529–529
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献